A meta-analysis of medicinal plants to assess the evidence for toxicity

Chen, Sarah; Vieira, Amandio

doi:10.2478/v10102-010-0016-0

Abstract

Toxicity of phytochemicals, plant-based extracts and dietary supplements, and medicinal plants in general, is of medical importance and must be considered in phytotherapy and other plant uses. We show in this report how general database analyses can provide a quantitative assessment of research and evidence related to toxicity of medicinal plants or specific phytochemicals. As examples, several medicinal plants are analyzed for their relation to nephrotoxicity and hepatotoxicity. The results of analyses in different databases are similar, and reveal the two best-established toxic effects among the group of plants that were examined: nephrotoxicity of Aristolochia fangchi and hepatotoxicity of Larrea tridentata.

References

Chatterjee KP. (1963). On the presence of an antidiabetic principle in Momordica charantia. Indian J Physiol Pharmacol 7: 240-4.
Search in Google Scholar
Debelle F, Nortier J, Arlt VM, De Prez E, Vienne A, Salmon I, Phillips DH, Deschodt-Lanckman M, Vanherweghem JL. (2003). Effects of dexfenfluramine on aristolochic acid nephrotoxicity in a rat model for Chinese-herb nephropathy. Arch Toxicol 77(4): 218-26.
Search in Google Scholar
Debelle FD, Nortier JL, De Prez EG, Garbar CH, Vienne AR, Salmon IJ, Deschodt-Lanckman MM, Vanherweghem JL. (2002). Aristolochic acids induce chronic renal failure with interstitial fibrosis in salt-depleted rats. J Am Soc Nephrol 13(2): 431-6.
Search in Google Scholar
Gay ML, Musser SM. (2008). Single-laboratory validated method for determination of nordihydro-guaiaretic acid in chaparral-containing dietary supplements. J AOAC Int 91(3): 501-5.
Search in Google Scholar
Ioset JR, Raoelison GE, Hostettmann K. (2003). Detection of aristolochic acid in Chinese phytomedicines and dietary supplements used as slimming regimens. Food Chem Toxicol 41(1): 29-36.
Search in Google Scholar
Jung M, Park M, Lee HC, Kang YH, Kang ES, Kim SK. (2006). Antidiabetic agents from medicinal plants. Curr Med Chem 13(10): 1203-18.
Search in Google Scholar
Kiefer D, Shah S, Gardiner P, Wechkin H. (2001). Finding information on herbal therapy: a guide to useful sources for clinicians. Altern Ther Health Med 7(6): 74-8.
Search in Google Scholar
Leatherdale BA, Panesar RK, Singh G, Atkins TW, Bailey CJ, Bignell AH. (1981). Improvement in glucose tolerance due to Momordica charantia (karela). Br Med J 282(6279): 1823-4.
Search in Google Scholar
Martinez MC, Nortier J, Vereerstraeten P, Vanherweghem JL. (2002). Progression rate of Chinese herb nephropathy: impact of Aristolochia fangchi ingested dose. Nephrol Dial Transplant 17(3): 408-12.
Search in Google Scholar
Ness J, Sherman FT, Pan CX. (1999). Alternative medicine: what the data say about common herbal therapies. Geriatrics 54(10): 33-8.
Search in Google Scholar
Sahu SC, Ruggles DI, O'Donnell MW. (2006). Prooxidant activity and toxicity of nordihydroguaiaretic acid in clone-9 rat hepatocyte cultures. Food Chem Toxicol 44(10): 1751-7.
Search in Google Scholar
Stickel F, Egerer G, Seitz HK. (2000). Hepatotoxicity of botanicals. Public Health Nutr 3(2): 113-24.
Search in Google Scholar
Suter E, Verhoef M, O'Beirne M. (2004). Assessment of the information needs and use of information resources on complementary and alternative medicine by Alberta family physicians. Clin Invest Med 27(6): 312-5.
Search in Google Scholar
Yadav UC, Moorthy K, Baquer NZ. (2005). Combined treatment of sodium orthovanadate and Momordica charantia fruit extract prevents alterations in lipid profile and lipogenic enzymes in alloxan diabetic rats. Mol Cell Biochem 268(1-2): 111-20.
Search in Google Scholar
Yuan M, Shi YB, Li ZH, Xia M, Ji GZ, Xu GX, Han Y. (2009). De novo urothelial carcinoma in kidney transplant patients with end-stage aristolochic acid nephropathy in China. Transplant Proc 41(5): 1619-23.
Search in Google Scholar

A meta-analysis of medicinal plants to assess the evidence for toxicity

Abstract

Paradigm

My account